Sanofi SA
OTC:SNYNF

Watchlist Manager
Sanofi SA Logo
Sanofi SA
OTC:SNYNF
Watchlist
Price: 94.73 USD 1.83% Market Closed
Market Cap: $118.7B

Net Margin

20.6%
Current
Improving
by 4.8%
vs 3-y average of 15.8%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
20.6%
=
Net Income
€13.8B
/
Revenue
€66.9B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
20.6%
=
Net Income
$13.8B
/
Revenue
€66.9B

Peer Comparison

Country Company Market Cap Net
Margin
FR
Sanofi SA
PAR:SAN
97.1B EUR
Loading...
US
Johnson & Johnson
NYSE:JNJ
541.8B USD
Loading...
UK
AstraZeneca PLC
LSE:AZN
216.3B GBP
Loading...
US
Merck & Co Inc
NYSE:MRK
269.1B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
175B USD
Loading...
US
Pfizer Inc
NYSE:PFE
151B USD
Loading...
DE
Bayer AG
XETRA:BAYN
45.7B EUR
Loading...
US
Eli Lilly and Co
NYSE:LLY
992.9B USD
Loading...
CH
Roche Holding AG
SIX:ROG
278.2B CHF
Loading...
CH
Novartis AG
SIX:NOVN
223.2B CHF
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...

Market Distribution

Higher than 91% of companies in France
Percentile
91st
Based on 2 398 companies
91st percentile
20.6%
Low
-147 400% — -2.2%
Typical Range
-2.2% — 7.1%
High
7.1% — 14 243.8%
Distribution Statistics
France
Min -147 400%
30th Percentile -2.2%
Median 2.6%
70th Percentile 7.1%
Max 14 243.8%

Sanofi SA
Glance View

Sanofi SA, a titan in the global healthcare sector, operates at the intricate crossroads of pharmaceutical innovation and patient care, driven by an unyielding commitment to improving human health. Emerging from its French roots, Sanofi has strategically positioned itself as a global leader in pharmaceuticals, vaccines, and consumer healthcare. The company’s success is essentially anchored in its capacity to consistently develop and commercialize life-saving drugs that address a myriad of health concerns, ranging from diabetes and cardiovascular diseases to rare disorders and oncology. Underlining its robust revenue engine is Sanofi's extensive R&D infrastructure that fuels its pipeline with groundbreaking therapies, reflecting a dynamic blend of scientific acumen and market-focused agility. By leveraging a hybrid model that integrates cutting-edge research with strategic alliances and acquisitions, Sanofi ensures a sustained presence in the highly competitive biopharmaceutical landscape. Enabling this network of innovation and impact is Sanofi's diverse portfolio, a balanced mix of specialty and established prescription drugs, over-the-counter products, and the critical arm of vaccines led by its Sanofi Pasteur division. This diversification offers both growth opportunities and stability, cushioning against the volatile tides of patent expirations and regulatory changes. Its vaccines segment, in particular, is a cornerstone in Sanofi's business, capturing substantial market share with products critical to global immunization efforts, further amplified by its role in responding to health emergencies like the COVID-19 pandemic. With a geographically expansive sales footprint and strategic marketing strategies, Sanofi capitalizes on emerging market opportunities while maintaining a strong presence in established regions, effectively making its bottom line a testimony to its operational excellence and strategic foresight in harmonizing science with humanity.

SNYNF Intrinsic Value
183.93 USD
Undervaluation 48%
Intrinsic Value
Price
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
20.6%
=
Net Income
€13.8B
/
Revenue
€66.9B
What is Sanofi SA's current Net Margin?

The current Net Margin for Sanofi SA is 20.6%, which is above its 3-year median of 15.8%.

How has Net Margin changed over time?

Over the last 3 years, Sanofi SA’s Net Margin has increased from 18.4% to 20.6%. During this period, it reached a low of 10.5% on Jun 30, 2024 and a high of 20.6% on Sep 30, 2025.

Back to Top